LATUDA
Peaklurasidone hydrochloride
NDAORALTABLET
Approved
Oct 2010
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
unclear. However, its efficacy in schizophrenia and bipolar depression could be mediated through a combination of central dopamine D 2 and serotonin Type 2 (5HT 2A ) receptor antagonism.
Indications (2)
Loss of Exclusivity
LOE Date
Nov 23, 2031
69 months away
Patent Expiry
Nov 23, 2031
Patent Records (5)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8729085 | May 26, 2026 | Product | — |
| 9907794 | May 26, 2026 | Product | — |
| 9555027 | May 26, 2026 | Product | U-543 |
| 8883794 | May 26, 2026 | Product | — |
| 9907794*PED | Nov 26, 2026 | — |